1 / 2

Global Male Cancer Market Receives Boost from Increasing Prevalence of Prostate Cancer

A new study by Transparency Market Research (TMR), titled “Male Cancer Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020,” presents a complete picture of the market by examining its driving forces, risks and hindrances, opportunities, major trends, and future prospects.<br><br>The research report states that the augmenting dominance of unhealthy lifestyles, the rising habit of smoking and drinking, increasing consumption of junk food, obesity, hereditary factors, and the growing exposure to carcinogenic elements have escalated the prevalence cancer among men across the world.

kksingha
Download Presentation

Global Male Cancer Market Receives Boost from Increasing Prevalence of Prostate Cancer

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Male Cancer Market Receives Boost from Increasing Prevalence of Prostate Cancer A new study by Transparency Market Research (TMR), titled “Male Cancer Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020,” presents a complete picture of the market by examining its driving forces, risks and hindrances, opportunities, major trends, and future prospects. The research report states that the augmenting dominance of unhealthy lifestyles, the rising habit of smoking and drinking, increasing consumption of junk food, obesity, hereditary factors, and the growing exposure to carcinogenic elements have escalated the prevalence cancer among men across the world. In this study, testicular cancer, prostate cancer, and penile cancer have been identified as the main types of cancer reported in men. Among these, prostate cancer exhibits the highest prevalence rate. According to the International Journal of Cancer, prostate cancer is the prime cause of death in geriatric males. On the other hand, testicular cancer is more prevalent in younger males in the age group of 20-40 years. Caucasian males are prone to testicular cancer while it rarely appears in those with Asian or African ethnicity. The treatment of this cancer includes surgery and boasts the highest success rate among male-specific cancer treatments. Penile cancer is relatively less prevalent globally. However, it has a considerable spread in third world economies. Human papillomavirus (HPV) is the root cause of this disease. The treatment of penile cancer mostly includes antiviral therapy, chemotherapy, and surgical excision. Further, the report states that the advancements in genomics and proteomics have boosted the market for male-specific cancer therapeutics in the recent times. The increase in research and development activities, leading to advanced treatments for cancerous tumors, is also propelling this market significantly. On the flip side, the high cost of treatments, together with the increasing incidence of their adverse effect on patients, is likely to limit the global market for male cancer therapeutics over the forecast period. However, high unmet needs in emerging countries, coupled with limited presence of local enterprises, is likely to present lucrative opportunities for international market players, notes the study.

  2. The competitive landscape prevalent in the global male protest cancer market has also been analyzed in this report on the basis of the performance and the future prospects of key organizations functioning in this market. Abbott Laboratories, Active Biotech, AstraZeneca Plc, Astellas Pharma Inc., Bristol-Myers Squibb, Dendreon Corp., Endo Pharmaceuticals Inc., Ipsen, Johnson & Johnson, Pfizer Inc., Sanofi-Aventis, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., Ferring Pharmaceuticals, and Tolmar Inc. are some of the major international companies that are developing treatments and medications for male cancers, states the research report. About Us Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports. Contact Us Transparency Market Research State Tower, 90 State Street, Suite 700, Albany NY - 12207 United States USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com

More Related